SCHEMBL19637221

SCHEMBL19637221

CCc1c(C)nc(SC)nc1N1CCNCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB1 P08588 1/20 0.47
▸ NUDT1 P36639 1/20 0.43
▸ KDM4E B2RXH2 4/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ MAPT P10636 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ HRH4 Q9H3N8 2/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ HTR2B P41595 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ ITGA2B P08514 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22994710 0.73 NUDT1 (0.41) NUDT1KDM4EALDH1A1HRH4KCNH2
SCHEMBL19453383 0.73 PKM (0.38) KDM4EALDH1A1MAPTNPC1KMT2A
Hydrazine SCHEMBL9427083 0.71 HRH4 (0.43) NUDT1KDM4EALDH1A1HRH4HTR2C
SCHEMBL12661856 0.69 L3MBTL1 (0.38) KDM4EALDH1A1MAPTHTR2AHTR2C
SCHEMBL1775878 0.68 HRH4 (0.52) NUDT1HRH4KCNH2HRH3
SCHEMBL30917635 0.66 NUDT1 (0.45) NUDT1KDM4EALDH1A1MAPTMEN1
Hydrochloric Acid SCHEMBL7298084 0.65 HTR2C (0.65) ADRB1HRH4HTR2C
SCHEMBL22011296 0.65 KDM4E (0.35) KDM4EALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL19637521 0.64 ADRB1 (0.46) ADRB1KDM4EALDH1A1HRH4HTR2A
SCHEMBL13875848 0.64 ADRB1 (0.41) ADRB1KDM4EALDH1A1HRH4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017201161-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2017-11-23 — — WO disclosed
Send feedback